What is the FDA's role in antifungal drug approval?

The FDA's primary role in the approval of antifungal drugs involves evaluating their safety and efficacy before they can be made available to the public. This process includes rigorous assessment of clinical trial data, which demonstrates how well the drug works in treating specific fungal infections and the potential side effects it may cause. The FDA ensures that these medications meet established standards for effectiveness and safety, which is crucial to protect public health.

Other options, such as setting prices, manufacturing drugs, or assessing market demand, are not part of the FDA's responsibilities. The FDA does not control pricing, nor is it involved in the actual production of drugs; rather, it focuses on regulating the pharmaceutical industry to ensure that all approved drugs, including antifungals, are safe for patient use.